Y. Li

机构：Chongqing Cancer Hospital

发表论文 2 篇 · 总被引 2 次 · h-index 1

代表论文

• 1166P A phase I study of JS207, a PD-1/VEGF bispecific antibody, in patients with advanced malignancies (2025 · Annals of Oncology · 被引 2)
• 1007P Prospective study of aumolertinib in NSCLC patients with EGFR sensitive mutations who are intolerant to osimertinib treatment (2025 · Annals of Oncology)